Safety Study of Navlimetostat Tablet in Healthy Women
This is an early-stage safety study testing a new tablet form of navlimetostat in healthy adult women. The goal is to understand how the body processes this drug and make sure it is safe and well-tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult woman with no significant medical conditions
- Your weight must be in a normal range (BMI between 18.0 and 35.0)
- Your kidney and liver function must be normal or nearly normal based on blood tests
- You must not have had stomach, intestinal, or pancreas problems in the last 3 months
- You must not have uncontrolled nausea, vomiting, or a recent weight-loss surgery
- You must be willing to have physical exams, heart tracings (ECG), and blood tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if stomach acid medicine and another drug affect how the body handles a new investigational drug. It helps researchers understand dosing for future patients.
This study looks at how the experimental drug navlimetostat is processed and removed from the body in healthy women. It helps researchers understand the drug's effects before it is tested in patients.
This trial checks how a new experimental drug (called Navlimetostat) interacts with other medicines and how food affects it. Healthy women participate to help researchers find the right dose and safety, which could later help people with cancer.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
This study tests a new slow-release tablet (Hemay5259) in healthy people. It aims to check how safe the drug is, how it works in the body, and whether food changes its effects. Participants will receive the drug and be closely monitored for side effects.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.